Brean Capital’s healthcare analyst Difei Yang weighed in this morning with a few insights on Zogenix (NASDAQ:ZGNX), after the healthcare research firm Symphony Health Solutions …
In a research report released Monday, Brean Capital analyst Difei Yang maintained a Buy rating on Zogenix (NASDAQ:ZGNX) with a $2.50 price target, …
Before the market opened Tuesday, Brean Capital analyst Difei Yang maintained a Buy rating on Zogenix (NASDAQ:ZGNX) with a price target of $2.50, …
In a research report issued Tuesday, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a price target of $2.50, …
In a research note published today, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a $2.50 price target, as the …
On Friday, August 1, Zogenix (ZGNX) announced the departure of Chief Commercial Officer Scott Shively at the same time Express Scripts (ESRX) decided to …
In a research note released Wednesday, William Blair analyst Tim Lugo reiterated coverage on Zogenix, Inc. (ZGNX) with a Buy rating, which represents a potential upside of 119% from where the …
